Records containing: Merkel Cell Carcinoma

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2023-03-02
A Phase 1b/2, Open-Label Study Evaluating the Safety and Efficacy of KRT-232 in Patients With p53 Wild-Type (p53WT) Merkel Cell Carcinoma (MCC) Who Have Failed Anti-PD-1 or Anti-PD-L1 Immunotherapy, or in Combination With Avelumab in MCC Patients Who Are Anti-PD-1 or Anti-PD-L1 Treatment Naïve
CLINICAL_TRIALS study record update · 2023-02-17
A Phase 3 Open-label, Single Arm Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) as First Line Therapy in Participants With Advanced Merkel Cell Carcinoma (KEYNOTE-913)
CLINICAL_TRIALS study record update · 2022-12-12
A Diagnostic Sensitivity Study Comparing Intradermal ICG and NIRFI With Intradermal Technetium 99m and Traditional Lymphoscintigraphy for Transcutaneous Identification of Sentinel Lymph Nodes in Malignant Melanoma
CLINICAL_TRIALS study record update · 2022-12-02
A Phase 1/2 Study of In Situ Vaccination With Tremelimumab and IV Durvalumab (MEDI4736) Plus the Toll-like Receptor Agonist Poly-ICLC in Subjects With Advanced, Measurable, Biopsy-accessible Cancers
CLINICAL_TRIALS study record update · 2022-11-18
A Phase II Efficacy Study of Chemo-Radiotherapy in PET Stage II and III Merkel Cell Carcinoma of the Skin
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2022-10-20
Optical Biopsy of Human Skin in Conjunction With Laser Treatment
CLINICAL_TRIALS study record update · 2022-07-15
A Phase 1 Study to Evaluate the Safety, Proliferation and Persistence of GEN-011, an Autologous Adoptive Cell Therapy Targeting Neoantigens in Solid Tumors
CLINICAL_TRIALS study record update · 2022-03-18
A Phase I, Open Label, Single Arm, Single Centre Study to Evaluate Mechanism of Action of Talimogene Laherparepvec (T-VEC) in Locally Advanced Non-melanoma Skin Cancer
CLINICAL_TRIALS study record update · 2021-11-18
A Phase II, Open Label, Multicenter Study to Investigate the Efficacy and Safety of Domatinostat in Combination With Avelumab in Patients With Treatment-naïve Metastatic Merkel Cell Carcinoma - the MERKLIN 1 Study
CLINICAL_TRIALS study record update · 2021-11-15
A Phase 1, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCAGN02390 in Participants With Select Advanced Malignancies
CLINICAL_TRIALS study record update · 2021-08-09
A Phase 2 Study of Palliative Radiation Therapy and Anti-PD-1/PD-L1 Checkpoint Blockade in Patients With Metastatic Merkel Cell Carcinoma
CLINICAL_TRIALS study record update · 2021-05-18
SerUM Markers in MERkel Cell Carcinoma Patients: a Longitudinal moniTorIng Study for optiMization of European Guidelines
CLINICAL_TRIALS study record update · 2021-03-09
French National Database of Rare Dermatological Cancers: Merkel Cell Carcinoma, Inoperable or Metastatic Basal Cell Carcinoma, Cutaneous Adnexal Carcinomas
CLINICAL_TRIALS study record update · 2020-12-29
MLN0128 in Recurrent/Metastatic Merkel Cell Carcinoma
CLINICAL_TRIALS study record update · 2020-10-30
A Phase 1 Open-Label, Dose-Escalation, Safety and Tolerability Study of INCAGN02385 in Participants With Select Advanced Malignancies
CLINICAL_TRIALS study record update · 2019-12-17
Phase II Open-Label Trial of Ipilimumab for Metastatic Merkel Cell Carcinoma
CLINICAL_TRIALS study record update · 2018-06-13
A Proof-of-Concept Clinical Trial of Intratumoral Injection of GLA-SE, a Toll-like Receptor-4 Agonist, in Patients With Merkel Cell Carcinoma
CLINICAL_TRIALS study record update · 2018-05-18
Phase II Study of the Tumor-targeting Human F16IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Paclitaxel in Patients With Metastatic Merkel Cell Carcinoma
CLINICAL_TRIALS study record update · 2017-12-12
A Phase II Study of Intratumoral Injection of Interleukin-12 Plasmid and in Vivo Electroporation in Patients With Merkel Cell Carcinoma
CLINICAL_TRIALS study record update · 2017-09-28
A Phase 1 Study of Veliparib (ABT-888) in Combination With Capecitabine and Temozolomide in Advanced Well-Differentiated Neuroendocrine Tumors
CLINICAL_TRIALS study record update · 2015-05-06
Videoscopic Versus Open Inguinal Lymphadenectomy for Sentinel Node Positive Cutaneous Malignancies and Genitourinary Staging Procedures
CLINICAL_TRIALS study record update · 2015-03-26
A Phase I, Open-Label, Dose Escalation Study of Daily Dosing With BB-10901
CLINICAL_TRIALS study record update · 2013-07-10
Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Metastatic or Incurable Neuroendocrine Tumors
CLINICAL_TRIALS study record update · 2010-04-15
The Impact of Total Body Skin Examination on Skin Cancer Detection